Annelies Heylen

ORCID: 0000-0002-2660-8984
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mitochondrial Function and Pathology
  • Adipose Tissue and Metabolism
  • Neuroscience and Neuropharmacology Research
  • Amyotrophic Lateral Sclerosis Research
  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Dementia and Cognitive Impairment Research
  • Tryptophan and brain disorders
  • Parkinson's Disease Mechanisms and Treatments
  • Diabetes Management and Research
  • Anesthesia and Neurotoxicity Research
  • Intensive Care Unit Cognitive Disorders
  • Cholinesterase and Neurodegenerative Diseases
  • Anesthesia and Sedative Agents
  • Neurological Disorders and Treatments
  • Chronic Disease Management Strategies

University of Antwerp
2021-2025

ETH Zurich
2024

University Medical Center Groningen
2023

University of Groningen
2023

Early-onset neurodegeneration leads to cognitive and behavioral symptoms in frontotemporal dementia (FTD) motor disturbances amyotrophic lateral sclerosis (ALS). Despite distinct clinical profiles, more than half of FTD patients experience ALS-related vice versa. Spinal cord monoamine neurotransmitter alterations were reported ALS, but not yet FTD. Therefore, we compared monoaminergic turnover across the FTD-ALS continuum. Reversed-phase, ultra-high-performance liquid chromatography with...

10.1111/jnc.70046 article EN Journal of Neurochemistry 2025-03-01

Objectives: Despite distinct clinical profiles, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) patients share a remarkable portion of pathological features, with substantial percentage displaying mixed disease phenotype. Kynurenine metabolism seems to play role in dementia-associated neuroinflammation has been linked both diseases. We aimed explore dissimilarities kynurenine pathway metabolites these early onset neurodegenerative disorders brain-region-specific manner....

10.3390/ph16040615 article EN cc-by Pharmaceuticals 2023-04-19

Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains major challenge. Here, we combine RNA sequencing with selective pharmacological, chemogenetic, and optogenetic manipulations isolate contribution locus coeruleus-noradrenaline (LC-NA) system stress response mice. We reveal that NA release during exposure regulates large reproducible set genes dorsal ventral...

10.7554/elife.88559 article EN cc-by eLife 2023-08-01

Abstract Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains major challenge. Here we combine RNA-sequencing with selective pharmacological, chemogenetic and optogenetic manipulations isolate contribution locus coeruleus - noradrenaline (LC-NA) system stress response. We reveal that NA-release during exposure regulates large reproducible set genes dorsal ventral...

10.1101/2023.02.02.526661 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-02-02

Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains major challenge. Here, we combine RNA sequencing with selective pharmacological, chemogenetic, and optogenetic manipulations isolate contribution locus coeruleus-noradrenaline (LC-NA) system stress response mice. We reveal that NA release during exposure regulates large reproducible set genes dorsal ventral...

10.7554/elife.88559.3 article EN cc-by eLife 2024-03-13

Abstract Objectives Delirium frequently arises in older demented and non‐demented patients postoperative, clinical settings. To date, the underlying pathophysiological mechanisms remain poorly understood. Monoamine neurotransmitter alterations have been linked to delirium cognitive impairment. Our aim was investigate if this holds true cognitively normal impaired experiencing following hip surgery. Methods Monoamines metabolites were measured plasma samples of 181 individuals by means...

10.1002/gps.5677 article EN International Journal of Geriatric Psychiatry 2021-12-28

Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains major challenge. Here we combine RNA-sequencing with selective pharmacological, chemogenetic and optogenetic manipulations isolate contribution locus coeruleus - noradrenaline (LC-NA) system stress response. We reveal that NA-release during exposure regulates large reproducible set genes dorsal ventral...

10.7554/elife.88559.2 preprint EN 2024-02-16

Abstract Background Down syndrome (DS, trisomy 21) is the most frequent genetic cause of intellectual disability (ID), prevalent in approximately 1 900 live births (Loane et al., 2013). People with DS are at high risk to develop Alzheimer’s disease dementia (AD) (Lott & Head, 2001). Onset clinical symptoms varies substantially time. Consequently, predicting and monitoring decline onset a diagnostic challenge, while it essence daily care support. Behavioral Psychological Symptoms Dementia...

10.1002/alz.092217 article EN cc-by Alzheimer s & Dementia 2024-12-01

Exposure to an acute stressor triggers a complex cascade of neurochemical events in the brain. However, deciphering their individual impact on stress-induced molecular changes remains major challenge. Here we combine RNA-sequencing with selective pharmacological, chemogenetic and optogenetic manipulations isolate contribution locus coeruleus - noradrenaline (LN-NA) system stress response. We reveal that NA-release during exposure regulates large reproducible set genes dorsal ventral...

10.7554/elife.88559.1 preprint EN 2023-08-01

Abstract Background Despite disease‐specific symptoms, differentiation between Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) remains challenging, especially in early, prodromal stages. This is fueled by overlapping pathology both diseases (Slaets et al., 2013). Monoamine neurotransmitters are significantly altered DLB AD capable of distinguishing from AD, when added to the panel cerebrospinal fluid (CSF) biomarkers (Aβ 1‐40 , Aβ 1‐42 T‐tau, P‐tau) as standalone (Janssens...

10.1002/alz.079838 article EN Alzheimer s & Dementia 2023-12-01

Abstract Background People with DS are at high risk to develop Alzheimer’s disease dementia (AD) (Lott & Head, 2001). Predicting and monitoring decline onset of is a diagnostic challenge essence in daily care support for people DS. Behavioral Psychological Symptoms Dementia (BPSD) an easily accessible tool the prediction population. The BPSD‐DS II scale was developed validated by our team identify behavioral changes linked AD between last six months pre‐existing behavior individual...

10.1002/alz.079687 article EN Alzheimer s & Dementia 2023-12-01
Coming Soon ...